Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Major Depressive Disorder Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01145755
What this trial is testing

6-week Study Treatment to Evaluate the Safety and Effectiveness of AZD2066 in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
AstraZeneca 131
Not applicableStudy completedNCT00039715
What this trial is testing

Effects of Hydrocortisone in Patients With Post-Traumatic Stress Disorder

Who this might be right for
Post-Traumatic Stress DisordersHealthy
National Institute of Mental Health (NIMH) 93
Early research (Phase 1)Study completedNCT01919008
What this trial is testing

Comparison of Plasma Concentration Changes Between Two Types of Tablets of FK949E Administration to Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Astellas Pharma Inc 16
Not applicableStudy completedNCT00531726
What this trial is testing

Berlin Deep Brain Stimulation Depression Study

Who this might be right for
Treatment Resistant Depression
Charite University, Berlin, Germany 11
Not applicableLooking for participantsNCT06601140
What this trial is testing

Evaluation of the Concordance Between Measures Obtained by a Medical Device for Emotional Monitoring (EMOCARE) and the Patient Health Questionnaire (PHQ-9) Score in Patients With Mild to Severe Depressive Episode

Who this might be right for
Major Depressive Disorder (MDD)
Emobot 104
Not applicableStudy completedNCT00818506
What this trial is testing

Associations Between Depression and Cardiovascular Disease - a Study of Patients With Late Onset Depression

Who this might be right for
DepressionMajor Depressive DisorderCardiovascular Disease+1 more
University of Aarhus 55
Not applicableLooking for participantsNCT07197138
What this trial is testing

IMPACT-D+: Immune-Modulating and Psychometric Effects of Accelerated TMS in Depression Plus Comorbid Post-COVID-19 Condition

Who this might be right for
Depressive DisorderPost-Acute COVID-19 Syndrome
Max-Planck-Institute of Psychiatry 42
Testing effectiveness (Phase 2)Study completedNCT06340958
What this trial is testing

CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive Disorder

Who this might be right for
Adjunctive Treatment of Major Depressive Disorder (MDD)
Clexio Biosciences Ltd. 99
Post-approval studies (Phase 4)WithdrawnNCT00878748
What this trial is testing

Study Evaluating Effexor XR in Chinese Subjects With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Wyeth is now a wholly owned subsidiary of Pfizer
Post-approval studies (Phase 4)Study completedNCT01458626
What this trial is testing

Effectiveness Study of Mirtazapine Combined With Paroxetine in Major Depressive Patients Without Early Improvement

Who this might be right for
Major Depression
Capital Medical University 525
Testing effectiveness (Phase 2)Ended earlyNCT01135758
What this trial is testing

Study of Depression-Ketamine-Brain Function

Who this might be right for
Major Depression
Markus KOSEL 10
Large-scale testing (Phase 3)Looking for participantsNCT06860958
What this trial is testing

Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients

Who this might be right for
Depressive Disorder, Major
Tanta University 60
Not applicableStudy completedNCT01887639
What this trial is testing

Prevalence and Risk Factors in Unipolar Depression Patients Without Remission After One Antidepressant Trial

Who this might be right for
Non-psychotic Unipolar Major Depression
AstraZeneca 200
Testing effectiveness (Phase 2)Study completedNCT03404466
What this trial is testing

To Explore the Safety and Efficacy of Hypidone Hydrochloride Tablets in Treatment of Patients With MDD

Who this might be right for
Major Depressive Disorder
Zhejiang Huahai Pharmaceutical Co., Ltd. 42
Post-approval studies (Phase 4)Looking for participantsNCT06675851
What this trial is testing

Reward-specific Changes of the Chemical Messenger Dopamine in the Brain of Healthy and Depressed People

Who this might be right for
Major Depressive Disorder (MDD)
Medical University of Vienna 120
Testing effectiveness (Phase 2)Study completedNCT05136365
What this trial is testing

Xiongdan Wan Treating Depression

Who this might be right for
Major Depressive Disorder
Shanghai Mental Health Center 30
Large-scale testing (Phase 3)Study completedNCT00067444
What this trial is testing

Depression Study In Elderly Patients

Who this might be right for
Depressive Disorder, MajorMajor Depressive Disorder (MDD)
GlaxoSmithKline 560
Not applicableUnknownNCT04717921
What this trial is testing

Assesment of Retinal Nerve Fiber Layer in First Episode Depressive Patients Using Selective Serotonin Reuptake Inhibitor

Who this might be right for
Unipolar Depression
Mehmet Diyaddin Güleken 60
Post-approval studies (Phase 4)UnknownNCT00519012
What this trial is testing

Benefits of Switching Antidepressants Following Early Nonresponse

Who this might be right for
Depression
Oizumi Hospital 200
Not applicableStudy completedNCT03841019
What this trial is testing

Predict MDE Outcomes After MST

Who this might be right for
Major Depressive Episode
Shanghai Mental Health Center 45
Next Page